Latest Trials Latest NewsFAQ

WASHINGTON UNIVERSITY SCHOOL OF MEDICINE

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1891-01-01

Employees: 10K

Market Cap: -

Website: http://www.medschool.wustl.edu

Clinical Trials

Neurofibromatosis Type 1 Patient Registry

Completed

Conditions: Neurofibromatosis Type 1

First Posted Date: 2011-08-04

Last Posted Date: 2017-07-25

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 2391

Registration Number: NCT01410006

Locations: 🇺🇸
Washington University, Saint Louis, Missouri, United States

PET Imaging of Endotoxin-induced iNOS Activation

Phase 1

Completed

Conditions: Pneumonia

Interventions: Drug: [18F](+/-)NOS

First Posted Date: 2011-08-02

Last Posted Date: 2014-04-21

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 19

Registration Number: NCT01407796

Locations: 🇺🇸
Washington University School of Medicne, St. Louis, Missouri, United States

Systems of Care for New Moms: Integrating Depression Treatment

Not Applicable

Completed

Conditions: Post-partum Depression

Interventions: Behavioral: Problem Solving Tools (PST)

First Posted Date: 2011-08-02

Last Posted Date: 2018-05-11

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 29

Registration Number: NCT01407783

Locations: 🇺🇸
Washington University and Nurses for Newborns Foundations, Saint Louis, Missouri, United States

Buffered Lidocaine for Loop Electrosurgical Excision Procedures (LEEPs)

Phase 2

Completed

Conditions: Uterine Cervical Dysplasia

Interventions: Drug: Non-buffered lidocaine
Drug: sodium bicarbonate buffered lidocaine

First Posted Date: 2011-07-29

Last Posted Date: 2014-07-28

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 56

Registration Number: NCT01405768

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Effectiveness of Oral Albendazole in the Treatment of Severe Acute Malnutrition

Not Applicable

Withdrawn

Conditions: Kwashiorkor
Marasmus

Interventions: Drug: Placebo
Drug: Albendazole

First Posted Date: 2011-07-15

Last Posted Date: 2014-01-28

Lead Sponsor: Washington University School of Medicine

Registration Number: NCT01395381

Locations: 🇲🇼
St. Louis Nutrition Project, Blantyre, Malawi

Cognitive Speed as an Objective Measure of Tinnitus

Completed

Conditions: Tinnitus

First Posted Date: 2011-07-15

Last Posted Date: 2012-08-23

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 108

Registration Number: NCT01395368

Locations: 🇺🇸
Washington University, St. Louis, Missouri, United States

Azacitidine After Chemotherapy and Donor Lymphocyte Infusion in Patients With Relapsed Acute Myeloid Leukemia or Myelodysplastic Syndrome Previously Treated With Donor Stem Cell Transplant

Phase 1

Completed

Conditions: Myelodysplastic Syndromes
Leukemia, Myeloid, Acute

Interventions: Drug: Pre-DLI Salvage Chemotherapy
Drug: Azacitidine
Biological: Donor Leukocyte Infusion (DLI)

First Posted Date: 2011-07-11

Last Posted Date: 2015-04-27

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 14

Registration Number: NCT01390311

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

PD4PD:Partnered Dance for Parkinson Disease

Phase 2

Completed

Conditions: Parkinson Disease

Interventions: Behavioral: Tango dancing

First Posted Date: 2011-07-06

Last Posted Date: 2015-12-09

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 62

Registration Number: NCT01388556

Locations: 🇺🇸
Washington University School of Medicine, St. Louis, Missouri, United States

Exploration of Cortical Neural Network in Patients With Bothersome Tinnitus

Terminated

Conditions: Tinnitus

Interventions: Behavioral: Task-Based Functional Magnetic Resonance Imaging (fMRI)

First Posted Date: 2011-06-30

Last Posted Date: 2012-03-02

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 7

Registration Number: NCT01385540

Locations: 🇺🇸
Washington University School of Medicine, St. Louis, Missouri, United States

Carbamazepine in Severe Liver Disease Due to Alpha-1 Antitrypsin Deficiency

Phase 2

Terminated

Conditions: Alpha-1-antitrypsin Deficiency
Liver Cirrhosis

Interventions: Drug: Drug-Carbamazepine (Tegretol XR)
Drug: Carbamazepine (Tegretol XR) Placebo

First Posted Date: 2011-06-23

Last Posted Date: 2021-10-12

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 20

Registration Number: NCT01379469

Locations: 🇺🇸
Washington University in St. Louis School of Medicine, Saint Louis, Missouri, United States
🇺🇸
Children's Hospital of Pittsburgh, UPMC, Pittsburgh, Pennsylvania, United States
🇺🇸
University of Pittsburgh Medical Center, Presbyterian Hospital, Pittsburgh, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy